Supha Pharmachem Ltd.

BSE: 539561

Sector: Services

Industry Group: Commercial Services & Supplies

Industry: Trading & Distributors

0.35+0.0 (+2.94%)

24 Jul, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Supha Pharmachem Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	TTM Sep 30

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	90	505	510	4,042	405	527
Cost of Operating Revenue	88	499	494	4,001	398	511
Gross Profit	2	6	16	40	7	15
Gross Margin	2.5	1.2	3.1	1.0	1.7	2.9
Total Operating Expenses	89	503	503	4,008	406	524
Operating Profit	1	2	7	33	-1	3
Operating Margin	0.7	0.3	1.4	0.8	-0.3	0.6
Financing Income/(Expense) - Net	-	0	0	17	6	-2
Profit before Taxes	1	2	7	50	4	16
Income Taxes	0	0	2	18	2	4
Profit after Tax	0	1	5	33	2	12
PAT Margin	0.5	0.2	1.1	0.8	0.5	2.3
EPS - Basic - ex Extraordinary Items	0.01	0.02	0.09	0.57	0.04	0.12
EPS - Diluted - ex Extraordinary Items	0.01	0.02	0.09	0.57	0.04	0.12
EBIT	1	2	7	33	-1	3
EBITDA	1	2	7	33	-1	3
EBITDA Margin	0.8	0.3	1.5	0.8	-0.3	0.6

Balance Sheet

Abridged

Understanding Balance Sheet

Supha Pharmachem Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Source:	AR	AR	AR	AR	AR
Total Current Assets	38	224	1,154	1,948	1,720
Long-Term Investments	-	-	-	-	-
Property Plant & Equipment - Net	0	0	0	0	0
Total Non-Current Assets	0	0	0	0	0
Total Assets	39	224	1,154	1,948	1,720
Total Current Liabilities	24	219	1,144	1,905	1,676
Long Term Debt	11	-	-	-	-
Total Non-Current Liabilities	11	0	-	-	0
Total Liabilities	35	219	1,144	1,905	1,676
Total Shareholders' Equity	4	5	10	43	44
Total Equity	4	5	10	43	44
Total Liabilities & Equity	39	224	1,154	1,948	1,720

Cash Flow

Abridged

Understanding Cash Flow Statement

Supha Pharmachem Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	1	1	6	37	4
Working Capital - Increase/(Decrease)	-11	10	15	-111	-1,144
Net CF from Operating Activities	-10	11	21	-74	-1,140
Capital Expenditures - Net	0	0	0	-	-
Net CF from Investing Activities	0	0	0	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	10	-11	-	58	1,141
Net Cash Flow from Financing Activities	10	-11	0	54	1,141
Free Cash Flow to Equity	0	1	20	-16	1
Free Operating CF net dividend	-10	11	20	-74	-1,140
Free Operating CF	-10	11	20	-74	-1,140

Business Segment Analysis

Supha Pharmachem Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Supha Pharmachem Ltd.

Regional Segment Analysis

Supha Pharmachem Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Supha Pharmachem Ltd.

Historical Segment Analysis

Track how Supha Pharmachem Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Supha Pharmachem Ltd.

Frequently Asked Questions

What is the revenue of Supha Pharmachem Ltd.?

The latest trailing twelve month revenue of Supha Pharmachem Ltd. is ₹ 526.90 Cr, reflecting a 1-year growth of -84.25% and a 3-year CAGR of 1.48%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Supha Pharmachem Ltd.?

The latest trailing twelve month net profit (PAT) of Supha Pharmachem Ltd. is ₹ 11.99 Cr, with a 3-year earnings CAGR of -4.36%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Supha Pharmachem Ltd.?

The trailing twelve month EBITDA of Supha Pharmachem Ltd. is approximately ₹ 3.29 Cr (based on an operating margin of 0.62%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Supha Pharmachem Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Supha Pharmachem Ltd. is 0.12. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Supha Pharmachem Ltd.?

The debt-to-equity ratio of Supha Pharmachem Ltd. stands at 10.34. The interest coverage ratio is -0.21x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Supha Pharmachem Ltd.?

The estimated book value per share of Supha Pharmachem Ltd. is 1.19 (derived from a P/B ratio of 0.29 and market price of ₹ 0.35), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Supha Pharmachem Ltd.?

The trailing twelve month operating cash flow of Supha Pharmachem Ltd. is ₹ -1,000.59 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Supha Pharmachem Ltd. report consolidated or standalone financials?

Supha Pharmachem Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.